Should bisphosphonates be used in premenopausal women?
Cohen
Adi
A
D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D017697:Premenopause
D050071:Bone Density Conservation Agents; D004164:Diphosphonates